6-ECDCA

Potent and selective FXR agonist (EC50= 99nM). Induces SHP in HSCs to suppress TIMP-1 expression. Apoptosis inducer. Protects against liver fibrosis development in rat in vivo. Displays anticholeretic activity in rat in vivo. Promotes preadipocyte differentiation. Regulates adipogenesis and insulin signaling in vivo. Inhibits vascular smooth muscle cell inflammation and migration.

Price Not Available 5 mg 6-ECDCA Supplier Page
Catalog Number AG-CR1-3560-M005
Alternative Name(s) 6alpha-Ethyl-chenodeoxycholic acid; 6-alpha-ECDC; Obeticholic acid; INT-747
Research Area Biochemicals, Immunology, Inflammation, Metabolism
Molecular Formula C26H44O4
CAS# 459789-99-2
Purity >95%
Inchi 1S/C26H44O4/c1-5-17-21-14-16(27)10-12-26(21,4)20-11-13-25(3)18(15(2)6-9-22(28)29)7-8-19(25)23(20)24(17)30/h15-21,23-24,27,30H,5-14H2,1-4H3,(H,28,29)/t15-,16-,17-,18-,19?,20?,21+,23?,24-,25-,26-/m1/s1
Inchi Key ZXERDUOLZKYMJM-AMGBFIHRSA-N
SMILES [H][C@@]12C[C@H](O)CC[C@]1(C)C1CC[C@]3(C)[C@H](CCC3C1[C@H](O)[C@@H]2CC)[C@H](C)CCC(O)=O
Size 5 mg
Supplier Page http://www.adipogen.com/ag-cr1-3560/6-ecdca.html